Role at ANSTO
Showing 81 - 100 of 146 results
Role at ANSTO
Role at ANSTO
Imaging and medical
The Imaging and Medical beamline (IMBL) is a flagship beamline of the Australian Synchrotron built with considerable support from the NHMRC. It is one of only a few of its type, and delivers the world’s widest synchrotron x-ray ‘beam’.
Role at ANSTO
The multi-purpose reactor OPAL, now in its 20th year, is not a power reactor
Australia has one multi-purpose nuclear reactor, the Open Pool Light Water Reactor (OPAL) and it is not used to generate ‘nuclear power’.
X-ray fluorescence scanning
X-ray fluorescence scanner is a powerful analytical tool for environmental studies.
Technical information - SAXS / WAXS
Technical information on the SAXS / WAXS beamline at the Australian Synchrotron.
Shaun Jenkinson is currently Chief Executive Officer of ANSTO.
Hijacker parasite blocked from infiltrating blood
International collaboration uses Australian Synchrotron on pioneering malaria research.
New antibody-like molecule which could be used in therapy to prevent infection from multiple forms of malaria
The protein mapping workhorses of the Australian Synchrotron, Macromolecular and Microfocus crystallography beamlines, MX1 and 2, continue to support important biomedical research in the development of vaccines and new therapeutics.
Role at ANSTO
Applications - Kowari
Applications, Recent results, Publications.
Role at ANSTO
Sydney Access Proposals
View the upcoming proposal deadlines for access to ANSTO’s Research Portal. The User Office provides support for research proposals and enables you to leverage our world-class research infrastructure and facilities.
Australian grads defy exodus for chance to work in science
Nuclear Medicine
ANSTO manufacture and supply a range of radiopharmaceuticals, radiochemicals, kits and accessories for use in research, industry and the health sector.
Part 2: What does a radiation event cost the aviation industry?
The cost of building radiation-hardness testing into the design and qualification of electronics is typically well under one per cent of a major project’s budget.
Role at ANSTO
Australian Synchrotron joins Monash and key institutions in $2.9 million new platform to support drug development
Monash University is partnering with the Australian Synchrotron and other key institutions to launch a $2.9 million national project – delivering a robotic laboratory capable of drastically speeding up the invention, trials and commercialisation of medicines by Australian researchers.